Cargando…
Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up
OBJECTIVE: This pilot study evaluates the pressure lowering potential of subthreshold micropulse diode laser trabeculoplasty (MDLT) for a clinically meaningful duration in patients with medically uncontrolled open angle glaucoma (OAG). DESIGN: prospective interventional case series. PARTICIPANTS: Th...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693967/ https://www.ncbi.nlm.nih.gov/pubmed/19668712 |
_version_ | 1782168025575718912 |
---|---|
author | Fea, Antonio Maria Bosone, Alex Rolle, Teresa Brogliatti, Beatrice Grignolo, Federico Maria |
author_facet | Fea, Antonio Maria Bosone, Alex Rolle, Teresa Brogliatti, Beatrice Grignolo, Federico Maria |
author_sort | Fea, Antonio Maria |
collection | PubMed |
description | OBJECTIVE: This pilot study evaluates the pressure lowering potential of subthreshold micropulse diode laser trabeculoplasty (MDLT) for a clinically meaningful duration in patients with medically uncontrolled open angle glaucoma (OAG). DESIGN: prospective interventional case series. PARTICIPANTS: Thirty-two eyes of 20 consecutive patients with uncontrolled OAG (12 bilateral and 8 unilateral). METHODS: Confluent subthreshold laser applications over the inferior 180° of the anterior TM using an 810 nm diode laser in a micropulse operating mode. The intraocular pressure (IOP) was measured at baseline and at 1 hour, 1 day, 1 week, 3, 6, 9, and 12 months post-treatment. Flare was measured with a Kowa FM 500 flare-meter at baseline and at 3 hours, 1 day, 1 week, and 12 months post-treatment. After treatment, the patients were maintained on their pre-treatment drug regimen. MAIN OUTCOME MEASURES: Criteria for treatment response were IOP reduction ≥3 mm Hg and IOP ≤21 mm Hg within the first week after MDLT. Eyes not complying to the above criteria during the follow-up were considered treatment failure. Mean IOP change and percentage of IOP reduction during the follow-up were calculated. RESULTS: One eye was analyzed for bilateral patients. A total of 20 eyes were thus included. Four eyes (20%) did not respond to treatment during the first week. One additional eye failed at the 6 month visit. The treatment was successful in 15 eyes (75%) at 12 months. The IOP was significantly lower throughout follow-up (p < 0.01). At 12 months, the mean percentage of IOP reduction in the 15 respondent eyes was 22.1% and 12 eyes (60%) had IOP reduction higher than 20%. During the first two postoperative days, one eye with pigmentary glaucoma experienced a significant increase of flare associated with an IOP spike (34 mm Hg) that was controlled with systemic drugs; afterwards it qualified as a respondent and completed the study. No increase of flare was found in any other patient. No peripheral anterior synechiae formed. CONCLUSIONS: In this case series, MDLT was effective in reducing IOP in 75% of medically insufficiently controlled OAG eyes without significant complications. This justifies randomized clinical studies to compare MDLT with current IOP lowering strategies. |
format | Text |
id | pubmed-2693967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-26939672009-08-10 Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up Fea, Antonio Maria Bosone, Alex Rolle, Teresa Brogliatti, Beatrice Grignolo, Federico Maria Clin Ophthalmol Original Research OBJECTIVE: This pilot study evaluates the pressure lowering potential of subthreshold micropulse diode laser trabeculoplasty (MDLT) for a clinically meaningful duration in patients with medically uncontrolled open angle glaucoma (OAG). DESIGN: prospective interventional case series. PARTICIPANTS: Thirty-two eyes of 20 consecutive patients with uncontrolled OAG (12 bilateral and 8 unilateral). METHODS: Confluent subthreshold laser applications over the inferior 180° of the anterior TM using an 810 nm diode laser in a micropulse operating mode. The intraocular pressure (IOP) was measured at baseline and at 1 hour, 1 day, 1 week, 3, 6, 9, and 12 months post-treatment. Flare was measured with a Kowa FM 500 flare-meter at baseline and at 3 hours, 1 day, 1 week, and 12 months post-treatment. After treatment, the patients were maintained on their pre-treatment drug regimen. MAIN OUTCOME MEASURES: Criteria for treatment response were IOP reduction ≥3 mm Hg and IOP ≤21 mm Hg within the first week after MDLT. Eyes not complying to the above criteria during the follow-up were considered treatment failure. Mean IOP change and percentage of IOP reduction during the follow-up were calculated. RESULTS: One eye was analyzed for bilateral patients. A total of 20 eyes were thus included. Four eyes (20%) did not respond to treatment during the first week. One additional eye failed at the 6 month visit. The treatment was successful in 15 eyes (75%) at 12 months. The IOP was significantly lower throughout follow-up (p < 0.01). At 12 months, the mean percentage of IOP reduction in the 15 respondent eyes was 22.1% and 12 eyes (60%) had IOP reduction higher than 20%. During the first two postoperative days, one eye with pigmentary glaucoma experienced a significant increase of flare associated with an IOP spike (34 mm Hg) that was controlled with systemic drugs; afterwards it qualified as a respondent and completed the study. No increase of flare was found in any other patient. No peripheral anterior synechiae formed. CONCLUSIONS: In this case series, MDLT was effective in reducing IOP in 75% of medically insufficiently controlled OAG eyes without significant complications. This justifies randomized clinical studies to compare MDLT with current IOP lowering strategies. Dove Medical Press 2008-06 /pmc/articles/PMC2693967/ /pubmed/19668712 Text en © 2008 Fea et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Fea, Antonio Maria Bosone, Alex Rolle, Teresa Brogliatti, Beatrice Grignolo, Federico Maria Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up |
title | Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up |
title_full | Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up |
title_fullStr | Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up |
title_full_unstemmed | Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up |
title_short | Micropulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up |
title_sort | micropulse diode laser trabeculoplasty (mdlt): a phase ii clinical study with 12 months follow-up |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693967/ https://www.ncbi.nlm.nih.gov/pubmed/19668712 |
work_keys_str_mv | AT feaantoniomaria micropulsediodelasertrabeculoplastymdltaphaseiiclinicalstudywith12monthsfollowup AT bosonealex micropulsediodelasertrabeculoplastymdltaphaseiiclinicalstudywith12monthsfollowup AT rolleteresa micropulsediodelasertrabeculoplastymdltaphaseiiclinicalstudywith12monthsfollowup AT brogliattibeatrice micropulsediodelasertrabeculoplastymdltaphaseiiclinicalstudywith12monthsfollowup AT grignolofedericomaria micropulsediodelasertrabeculoplastymdltaphaseiiclinicalstudywith12monthsfollowup |